Literature DB >> 20620532

Superiority of visipaque (iodixanol)-controlled density gradient over Ficoll-400 in adult porcine islet purification.

T Min1, L Yi, Z Chao, Z Haitao, W Wei, Y Liang, W Bo.   

Abstract

OBJECTIVE: Sufficient and favorable biological functions of islets are major problems hindering xenotransplantation. The aim of the present study was to evaluate the effects on harvesting, purity, viability, and function of using improved Visipaque (iodixanol) and Ficoll-400 for adult porcine islet purification.
METHODS: Twelve adult porcine pancreata were randomly divided into an Iodixanol-University of Wisconsin (UW) group and a Ficoll-400-UW group according to the purification method. Porcine pancreata were isolated by collagenase digestion. After isolation and purification, the islet yield and purity were evaluated by dithizone staining, and islet function assessed by in vitro insulin release assays and in vivo islet xenotransplantation.
RESULTS: There were no marked differences in the islet yield before purification (5254.67 +/- 189.44 IEQ/g vs 5092.67 +/- 178.94 IEQ/g, P > .05). After purification, there were significantly more islets harvested in Iodixanol-UW group than in the Ficoll-400-UW group: 4222.00 +/- 228.84 IEQ/g vs 3036.83 +/- 79.60 IEQ/g (P < .05). Islets from the two groups showed satisfactory insulin secretory ability. There were no significant differences in islet survival times between the two groups in diabetic rats: 8.2 +/- 1.619 days vs 6.9 +/- 1.197 days (P > .05).
CONCLUSION: The improved iodixanol-UW density gradient method was superior to Ficoll-400 method to improve the number, viability, and insulin secret of purified adult porcine islets although the benefits did not improve in vivo survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620532     DOI: 10.1016/j.transproceed.2010.01.068

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Engineering Strategies to Improve Islet Transplantation for Type 1 Diabetes Therapy.

Authors:  Alisa M White; James G Shamul; Jiangsheng Xu; Samantha Stewart; Jonathan S Bromberg; Xiaoming He
Journal:  ACS Biomater Sci Eng       Date:  2019-12-02

2.  Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.

Authors:  Cyrus Jahansouz; Cameron Jahansouz; Sean C Kumer; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-15

Review 3.  Pig-islet xenotransplantation: recent progress and current perspectives.

Authors:  Hai-Tao Zhu; Wan-Li Wang; Liang Yu; Bo Wang
Journal:  Front Surg       Date:  2014-03-24

4.  A rapid, efficient, and economic device and method for the isolation and purification of mouse islet cells.

Authors:  Yin Zongyi; Zou Funian; Li Hao; Cheng Ying; Zhang Jialin; Li Baifeng
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

5.  Alternative immunomodulatory strategies for xenotransplantation: CD80/CD86-CTLA4 pathway-modified immature dendritic cells promote xenograft survival.

Authors:  Min Tian; Yi Lv; Chao Zhai; Haitao Zhu; Liang Yu; Bo Wang
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.